Cargando…
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
OBJECTIVES: Loss of functional β-cell mass is a key factor contributing to poor glycemic control in advanced type 2 diabetes (T2D). We have previously reported that the inhibition of the neuropeptide Y1 receptor improves the islet transplantation outcome in type 1 diabetes (T1D). The aim of this stu...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733231/ https://www.ncbi.nlm.nih.gov/pubmed/34890851 http://dx.doi.org/10.1016/j.molmet.2021.101413 |